Guru Ownership Trend
Guru Analysis for Crinetics Pharmaceuticals, Inc. (CRNX)
Crinetics Pharmaceuticals, Inc. (CRNX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $118.91 M.
Top institutional holders include Steven Cohen and Ken Fisher.
Institutional sentiment is currently Bullish. This is evidenced by a $15.55 M net inflow during the quarter.
Recent activity highlights Steven Cohen who increased their stake by 16.7%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Crinetics Pharmaceuticals, Inc. (CRNX)
Major holders include Steven Cohen ($108.79 M), Ken Fisher ($35.32 M). According to the latest reported data, 2 tracked investment managers collectively hold approximately 3.1 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $15.55 M, with 2 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in CRNX during the most recent reporting period.
Yes, 0 managers opened new positions in CRNX, and 2 increased their existing holdings. The total reported buy value was $15.55 M.